KeyBanc Reiterates a 'Buy' on Francesca's Holdings (FRAN); Remains One of Our Top Growth Ideas
Tweet
Share
E-mailGet Alerts FRAN Hot Sheet
Price: $2.22 --0%
Rating Summary:
9 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
9 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
KeyBanc reiterates a 'Buy' on Francesca's Holdings (NASDAQ: FRAN) price target raised from $30 to $34.
Analyst, Edward Yruma, said, "As we have noted in our previous notes, FRAN’s superior 4-wall model (150% cash-on-cash returns) and unit growth opportunity (75 stores per year) give it one of the best long-term growth stories in our coverage. We think that 4Q’s 14.7% comp will allay concerns about FRAN’s (wrongly) perceived inability to comp. We are raising our 2012 EPS estimate from $0.74 to $0.80 and believe that the estimate could still prove conservative should momentum continue."
For an analyst ratings summary and ratings history on Francesca's Holdings click here. For more ratings news on Francesca's Holdings click here.
Shares of Francesca's Holdings closed at $26.78 yesterday.
Analyst, Edward Yruma, said, "As we have noted in our previous notes, FRAN’s superior 4-wall model (150% cash-on-cash returns) and unit growth opportunity (75 stores per year) give it one of the best long-term growth stories in our coverage. We think that 4Q’s 14.7% comp will allay concerns about FRAN’s (wrongly) perceived inability to comp. We are raising our 2012 EPS estimate from $0.74 to $0.80 and believe that the estimate could still prove conservative should momentum continue."
For an analyst ratings summary and ratings history on Francesca's Holdings click here. For more ratings news on Francesca's Holdings click here.
Shares of Francesca's Holdings closed at $26.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
KeyBancSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
